Botulinum Toxin Injection for Spasticity: Common Sites

Status: draft · Last updated 2026-11-19 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • Effect lasts about 12 weeks .
  • Systemic events (incontinence about 1%, respiratory admissions 1.3%) rise with GMFCS level and dose .
  • Common targets: calf (equinus), hamstrings, adductors, tibialis posterior; biceps, pronator teres, wrist and finger flexors, thumb (see caveats).
  • Phenol obturator blocks for adductor tone .

Indications

Basic procedural flow

Risks

Postoperative management

Related topics

References

  1. Alghadier M, Alsuwayegh A. Efficacy of botulinum toxin type A for spasticity management and motor function in children with cerebral palsy: a systematic review and meta-analysis of randomized controlled trials. Front Neurol 2026;17:1751493. doi:10.3389/fneur.2026.1751493. PMID 41809197. verified
  2. Kwon JY, Kim JS. Selective blocking of the anterior branch of the obturator nerve in children with cerebral palsy. Am J Phys Med Rehabil 2009;88(1):7–13. doi:10.1097/PHM.0b013e31815b6381. PMID 17993980. verified
  3. Naidu K, Smith K, Sheedy M, et al. Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy. Dev Med Child Neurol 2010;52(2):139–144. doi:10.1111/j.1469-8749.2009.03583.x. PMID 20412252. verified

Verification (2026-11-19):

Caveats: